Mello Healthcare Presentation 25th May 2021

RNS Number : 3329Z

Inspiration Healthcare Group PLC

20 May 2021

 

Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Group" and the "Company")

Inspiration Healthcare Group plc to present at Mello Healthcare; Invest in Good Health on Tuesday 25^th May 2021, via Zoom Webinar

Inspiration Healthcare (AIM: IHC), the global medical technology company, is pleased to announce that the Company will be attending Mello Healthcare; Invest in Good Health on Tuesday 25^th May 2021 taking place from 6pm to 9.30pm. Neil Campbell, CEO and Jon Ballard, CFO, will be presenting and taking questions from participants.  If you would like to attend, you can register here for the event using code SHVIP75 .

For further information on the Mello London conference, please visit the event website https://melloevents.com/

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: [phone]
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys	Tel: [phone]
Cadogan PR  Alex Walters [e-mail]	Tel: [phone]

About the Group:

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres with a focus on neonatal care. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the world through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all of which can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3rd party companies that wish to access the UK and the Republic of Ireland's health systems using the Group's sales and service expertise and knowledge of these healthcare providers. The therapy areas in which we distribute products such as Infusion, Respiratory and Developmental Care add value to our product portfolio.

The Group invests in growth through its Research and Development function holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

 

END

 

 

NRAURAORARUVUAR